Age: 29
Free Agency: 2024 (UFA)
Accrued Seasons: 5
- Height: 6'7"
- Weight: 358
- College: TCU
- Entry: 2018 Draft, Round 6, #206 overall (Eagles)
- 2023 Salary Cap Charge: $990,000 (0.42% of cap)
- 2023 Cash Payout: $1,130,000 (0.43% of spending)
- 2023 Cash to Cap Ratio: 1.14
- Contract Value: $1,130,000 ($1,130,000 APY)
- Fully Guaranteed Money: $0
- Contract Ranking: 48/101 at LT
Current Contract
(UFA, signed 2023)
(📝: indicates contract trigger occuring during that year)Year | Age | Base Salary | Workout Bonus | Cap Number | Cap % | Dead Money & Cap Savings | |||
---|---|---|---|---|---|---|---|---|---|
2023 | 29 | $1,080,000 | $50,000 | $990,000 | 0.4% | ||||
Total | $1,080,000 | $50,000 | $990,000 |
Contract Notes
Matt Pryor signed a one year contract with the Indianapolis Colts worth base value $5.45 million with $5.29 million guaranteed at signing. Pryor received a $4 million roster bonus at signing. There is an additional $500,000 available through incentives for playtime.
Cash Flows
2023 | |
---|---|
Cash Due | $1,130,000 |
Running Cash | $1,130,000 |
Career Earnings: $8,482,784
Career APY: $1,696,557
Contract History
Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
---|---|---|---|---|---|---|---|---|---|---|
Eagles | Drafted | Traded | 2018 | 4 | $2,592,784 | $648,196 | $132,784 | $1,932,784 | 74.5% | $644,261 |
Colts | Drafted | Expired | 2018 | 4 | $2,592,784 | $648,196 | $132,784 | $920,000 | 35.5% | $920,000 |
Colts | UFA | Expired | 2022 | 1 | $5,545,000 | $5,545,000 | $5,290,000 | $5,630,000 | 101.5% | $5,630,000 |
49ers | UFA | Active | 2023 | 1 | $1,130,000 | $1,130,000 | $0 | $0 | 0.0% | $0 |
Earnings By Team
Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
---|---|---|---|---|---|---|---|
Eagles | 3 | $1,932,784 | $644,261 | $1,899,588 | 0.0% | $33,196 | 0.0% |
Colts | 2 | $6,550,000 | $3,275,000 | $6,465,000 | 0.0% | $0 | 0.0% |
49ers | 0 | $0 | $0 | $0 | 0.0% | $0 | 0.0% |
Season History
Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Per Game Roster Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2018 | Eagles | $480,000 | $33,196 | $0 | $0 | $0 | $0 | $513,196 | 0.3% | $612,784 | ||
2019 | Eagles | $570,000 | $33,196 | $0 | $0 | $0 | $0 | $603,196 | 0.3% | $570,000 | ||
2020 | Eagles | $750,000 | $33,196 | $0 | $0 | $0 | $0 | $783,196 | 0.4% | $750,000 | ||
2021 | Colts | $920,000 | $0 | $0 | $0 | $0 | $0 | $920,000 | 0.5% | $920,000 | ||
2022 | Colts | $1,290,000 | $0 | $4,000,000 | $255,000 | $0 | $5,290,000 | $5,545,000 | 2.6% | $5,630,000 | ||
2023 | 49ers | $1,080,000 | $0 | $0 | $0 | $50,000 | $0 | $990,000 | 0.4% | $1,130,000 | ||
Total | $5,090,000 | $99,588 | $4,000,000 | $255,000 | $50,000 | $5,290,000 | $9,354,588 | $9,612,784 |
Dead Money History
Team | Year | Cap Charge | Cash Paid |
---|---|---|---|
Eagles | 2021 | $33,196 | $0 | Total | $33,196 | $0 |
Statistics
Year | Games Played | Games Inactive | Snaps | ||
---|---|---|---|---|---|
Injured | Healthy | Offense | Special | ||
2019 | 12 | 0 | 4 | 6.7% | 10.7% |
2020 | 15 | 0 | 0 | 68.5% | 10.4% |
2021 | 17 | 0 | 0 | 39.6% | 18.9% |
2022 | 16 | 0 | 1 | 50.1% | 12.1% |
2023 | 2 | 0 | 0 | 0.0% | 24.1% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
OTC Valuation | APY | |
---|---|---|
Regular | $0 | $0 |
Injury Adjusted | $0 | $0 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.